TCEA3

Summary

TCEA3 (transcription elongation factor A3, HGNC:11615) is a protein-coding gene on chromosome 1p36.12, encoding Transcription elongation factor A protein 3 (O75764). Necessary for efficient RNA polymerase II transcription elongation past template-encoded arresting sites.

Predicted to enable DNA binding activity; translation elongation factor activity; and zinc ion binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.

Source: NCBI Gene 6920 — RefSeq curated summary.

At a glance

• GWAS associations: 60
• Clinical variants (ClinVar): 75 total
• MANE Select transcript: NM_003196

Identifiers

Gene identifiers

Field	Value
HGNC ID	HGNC:11615
Approved symbol	TCEA3
Name	transcription elongation factor A3
Location	1p36.12
Locus type	gene with protein product
Status	Approved
Aliases	TFIIS.H
Ensembl gene	ENSG00000204219
Ensembl biotype	protein_coding
OMIM	604128
Entrez	6920

Gene structure

Transcript identifiers

Ensembl transcripts: 22 — 20 protein_coding, 2 retained_intron

ENST00000374601, ENST00000374602, ENST00000450454, ENST00000461794, ENST00000476978, ENST00000492271, ENST00000898818, ENST00000898819, ENST00000898820, ENST00000898821, ENST00000898822, ENST00000898823, ENST00000898824, ENST00000898825, ENST00000898826, ENST00000941055, ENST00000941056, ENST00000941057, ENST00000941058, ENST00000941059, ENST00000941060, ENST00000941061

RefSeq mRNA: 1 — MANE Select: NM_003196 NM_003196

CCDS: CCDS44086

Canonical transcript exons

ENST00000450454 — 11 exons

Exon	Start	End
ENSE00001463958	23380909	23381474
ENSE00001463967	23397792	23397955
ENSE00001463973	23419077	23419139
ENSE00001463974	23424565	23424748
ENSE00001592094	23397545	23397601
ENSE00001641729	23393879	23394033
ENSE00003464044	23384346	23384417
ENSE00003478049	23417249	23417390
ENSE00003484973	23417904	23418009
ENSE00003543012	23408664	23408726
ENSE00003559521	23387273	23387419

Expression profiles

Bgee: expression breadth ubiquitous, 134 present calls, max score 99.23.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 7.7784 / max 414.4001, expressed in 981 samples.

FANTOM5 promoters (5 alternative TSS)

Promoter ID	TPM avg	Samples expressed
10972	6.7101	919
10973	0.8501	367
10970	0.1104	49
10971	0.1029	49
10974	0.0049	1

Top tissues by expression

134 total, by Bgee expression score (0-100, higher = more expressed):

Tissue	Anatomy ID	Expression score	Quality
skeletal muscle tissue	UBERON:0001134	99.23	gold quality
hindlimb stylopod muscle	UBERON:0004252	99.12	gold quality
gastrocnemius	UBERON:0001388	98.91	gold quality
muscle of leg	UBERON:0001383	98.83	gold quality
body of pancreas	UBERON:0001150	98.65	gold quality
mucosa of transverse colon	UBERON:0004991	97.41	gold quality
right lobe of liver	UBERON:0001114	97.12	gold quality
rectum	UBERON:0001052	96.79	gold quality
liver	UBERON:0002107	96.78	gold quality
right adrenal gland	UBERON:0001233	96.65	gold quality
sural nerve	UBERON:0015488	96.65	gold quality
muscle tissue	UBERON:0002385	96.58	gold quality
right adrenal gland cortex	UBERON:0035827	96.53	gold quality
left adrenal gland cortex	UBERON:0035825	96.15	gold quality
left adrenal gland	UBERON:0001234	96.06	gold quality
saliva-secreting gland	UBERON:0001044	95.72	gold quality
transverse colon	UBERON:0001157	95.60	gold quality
right uterine tube	UBERON:0001302	95.55	gold quality
adrenal tissue	UBERON:0018303	95.55	gold quality
minor salivary gland	UBERON:0001830	95.53	gold quality
adrenal gland	UBERON:0002369	95.36	gold quality
apex of heart	UBERON:0002098	95.05	gold quality
left ovary	UBERON:0002119	95.02	gold quality
ovary	UBERON:0000992	95.00	gold quality
calcaneal tendon	UBERON:0003701	94.98	gold quality
fundus of stomach	UBERON:0001160	94.80	gold quality
heart left ventricle	UBERON:0002084	94.68	gold quality
body of stomach	UBERON:0001161	94.52	gold quality
stomach	UBERON:0000945	94.39	gold quality
cortex of kidney	UBERON:0001225	94.12	gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 1.

Experiment	Marker?	Max mean expression
E-ANND-3	yes	22.29
E-GEOD-83139	no	2.75

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

25 targeting TCEA3, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNA	Max score	Avg score	miRNA target_count
HSA-MIR-3925-3P	100.00	69.95	1237
HSA-MIR-4775	99.98	75.00	6394
HSA-MIR-515-5P	99.92	69.82	2343
HSA-MIR-519E-5P	99.92	69.62	2358
HSA-MIR-576-5P	99.84	70.46	2582
HSA-MIR-92A-2-5P	99.75	67.01	2164
HSA-MIR-17-3P	99.55	66.77	1311
HSA-MIR-1324	99.46	66.57	1302
HSA-MIR-330-3P	99.41	69.95	2521
HSA-MIR-6731-5P	99.28	67.42	2375
HSA-MIR-8085	99.28	67.56	2362
HSA-MIR-4505	99.27	67.81	2678
HSA-MIR-5787	99.22	67.86	2628
HSA-MIR-371A-5P	99.08	66.51	1914
HSA-MIR-6871-5P	98.90	66.67	671
HSA-MIR-16-1-3P	98.70	69.23	1538
HSA-MIR-7155-5P	98.65	66.14	1290
HSA-MIR-6881-5P	98.16	67.38	665
HSA-MIR-4799-3P	97.78	65.97	893
HSA-MIR-4720-5P	97.46	65.67	893
HSA-MIR-5588-5P	97.46	65.70	913
HSA-MIR-5000-5P	97.40	66.11	1055
HSA-MIR-3976	96.67	67.79	1187
HSA-MIR-6742-5P	96.32	64.01	869
HSA-MIR-29C-5P	87.36	66.96	29

Literature-anchored findings (GeneRIF, showing 6)

• Study demonstrates a strong synergy between hPAF1C and elongation factor SII/TFIIS and an underlying mechanism involving direct hPAF1C-SII interactions and cooperative binding to RNA polymerase II. (PMID:20178742)
• Tcea3 binds to TGF-beta I receptor and activates TGF-beta signaling pathway. (PMID:23357533)
• TCEA3 attenuates the proliferation and induces apoptosis of gastric cancer cells (PMID:26498664)
• Findings reveal a novel mechanism by which p53 utilizes TFIIS.h to selectively promote the transcriptional elongation of the bax gene, upsurging cell death in response to severe DNA damage. (PMID:27005522)
• The transcription elongation factor TCEA3 induces apoptosis in rhabdomyosarcoma. (PMID:31988307)
• Oncogenic tRNA-derived fragment tRF-Leu-CAG promotes tumorigenesis of lung cancer via targeting TCEA3 and increasing autophagy. (PMID:39198937)

Cross-species orthologs

3 orthologs

Organism	Symbol	Gene ID
danio_rerio	tcea3	ENSDARG00000004724
mus_musculus	Tcea3	ENSMUSG00000001604
rattus_norvegicus	Tcea3	ENSRNOG00000011794

Paralogs (3): TCEA2 (ENSG00000171703), TCEANC (ENSG00000176896), TCEA1 (ENSG00000187735)

Protein

Protein identifiers

Transcription elongation factor A protein 3 — O75764 (reviewed: O75764)

Alternative names: Transcription elongation factor S-II protein 3, Transcription elongation factor TFIIS.h

All UniProt accessions (3): O75764, S4R3M9, S4R419

UniProt curated annotations — full annotation on UniProt →

Function. Necessary for efficient RNA polymerase II transcription elongation past template-encoded arresting sites. The arresting sites in DNA have the property of trapping a certain fraction of elongating RNA polymerases that pass through, resulting in locked ternary complexes. Cleavage of the nascent transcript by S-II allows the resumption of elongation from the new 3’-terminus.

Subcellular location. Nucleus.

Similarity. Belongs to the TFS-II family.

Isoforms (2)

UniProt ID	Names	Canonical?
O75764-1	1	yes
O75764-2	2

RefSeq proteins (1): NP_003187* (*=MANE)

Domains & families (InterPro)

ID	Name	Type
IPR001222	Znf_TFIIS	Domain
IPR003617	TFIIS/CRSP70_N_sub	Domain
IPR003618	TFIIS_cen_dom	Domain
IPR006289	TFSII	Family
IPR017923	TFIIS_N	Domain
IPR035100	TF_IIS-typ	Family
IPR035441	TFIIS/LEDGF_dom_sf	Homologous_superfamily
IPR036575	TFIIS_cen_dom_sf	Homologous_superfamily

Pfam: PF01096, PF07500, PF08711

UniProt features (16 total): binding site 4, compositionally biased region 3, domain 2, modified residue 2, splice variant 2, chain 1, zinc finger region 1, region of interest 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

Model	pLDDT	Fraction very-high
AF-O75764-F1	74.57	0.34

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Ligand- & substrate-binding residues (4): 338; 341; 310; 313

Post-translational modifications (2): 115, 140

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 103 (showing top): BENPORATH_ES_WITH_H3K27ME3, MAZ_Q6, MEF2_02, SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN, GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN, SANSOM_APC_TARGETS_DN, HNF1_01, MEF2_Q6_01, CTAWWWATA_RSRFC4_Q2, WENG_POR_TARGETS_GLOBAL_UP, MEF2_03, MASSARWEH_TAMOXIFEN_RESISTANCE_UP, KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP, NUYTTEN_NIPP1_TARGETS_DN, DODD_NASOPHARYNGEAL_CARCINOMA_DN

GO Biological Process (3): regulation of transcription by RNA polymerase II (GO:0006357), transcription elongation by RNA polymerase II (GO:0006368), DNA-templated transcription (GO:0006351)

GO Molecular Function (5): DNA binding (GO:0003677), zinc ion binding (GO:0008270), nucleic acid binding (GO:0003676), protein binding (GO:0005515), metal ion binding (GO:0046872)

GO Cellular Component (1): nucleus (GO:0005634)

GO top-level categories

Rollup of top GO terms by namespace:

Category	Terms
transcription by RNA polymerase II	2
binding	2
regulation of DNA-templated transcription	1
DNA-templated transcription elongation	1
gene expression	1
RNA biosynthetic process	1
nucleic acid binding	1
transition metal ion binding	1
cation binding	1
intracellular membrane-bounded organelle	1

Protein interactions and networks

STRING

1680 interactions, top by confidence (×1000):

Protein A	Protein B	Partner UniProt	Score
TCEA3	GTF2B	Q00403	894
TCEA3	SUPT4H1	P63272	872
TCEA3	SUPT5H	O00267	868
TCEA3	POLR2I	P36954	834
TCEA3	TBP	P20226	808
TCEA3	SUPT6H	Q7KZ85	806
TCEA3	POLR2B	P30876	802
TCEA3	PLAG1	Q6DJT9	763
TCEA3	POLR1H	Q9P1U0	750
TCEA3	POLI	Q9UNA4	729
TCEA3	POLR3K	Q9Y2Y1	719
TCEA3	POLR2A	P24928	717
TCEA3	LEO1	Q8WVC0	713
TCEA3	ELOA2	Q8IYF1	706
TCEA3	ELOA	Q14241	694

IntAct

8 interactions, top by confidence:

A	B	Type	Score
TCEA3	LEO1	psi-mi:“MI:0915”(physical association)	0.560
SAV1	TCEA3	psi-mi:“MI:0915”(physical association)	0.370
RPH3AL	TCEA3	psi-mi:“MI:0915”(physical association)	0.370
M		psi-mi:“MI:0914”(association)	0.350
TCEA1	TCEA3	psi-mi:“MI:0914”(association)	0.350
LEO1	TCEA3	psi-mi:“MI:0915”(physical association)	0.000

BioGRID (12): TCEA3 (Two-hybrid), TCEA3 (Protein-RNA), TCEA3 (Affinity Capture-RNA), TCEA3 (Affinity Capture-MS), USP47 (Affinity Capture-Western), TCEA3 (Affinity Capture-Western), TCEA3 (Affinity Capture-MS), TCEA3 (Affinity Capture-MS), TCEA3 (Cross-Linking-MS (XL-MS)), TCEA3 (Cross-Linking-MS (XL-MS)), TCEA3 (Cross-Linking-MS (XL-MS)), TCEA3 (Two-hybrid)

ESM2 similar proteins: A2VE39, B0UYI1, D2HRF1, O46563, O60308, O75764, P10711, P23193, P23881, P54729, Q0P5J9, Q148K0, Q15560, Q29RL9, Q2KI09, Q4KLL0, Q5R8Y3, Q5R952, Q5R981, Q5U2Z5, Q5XGZ8, Q5XIC7, Q5ZM30, Q63799, Q6GQ76, Q7ZYU8, Q803R5, Q84ZC0, Q8BVE3, Q8BW49, Q8N1G2, Q8R2M0, Q8R3N6, Q8VDS4, Q8VI84, Q8WTT2, Q91Y26, Q95LY5, Q96MN5, Q96P16

Diamond homologs: A6ZZW1, O44498, O75764, P10711, P20232, P23193, P36106, P52652, Q29RL9, Q2KI09, Q4KLL0, Q6FJ00, Q6ZMY3, Q9U263, A5PKE4, B0UYI1, F4J4Y5, P23881, Q148K0, Q5XIC7, Q8R2M0, Q96MN5, Q9FHK9, Q14241, Q63187, Q8CB77, O13896, O27369, O29033, P07273, P36958, P49373, Q04307, Q07271, Q2M2S7, Q56254, Q58548, Q5JF34, Q5UQS8, Q980K2

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

75 variants total. Per-class counts are floors (≥ shown; pagination cap):

Classification	Count (floor)
Pathogenic	0
Likely pathogenic	0
Uncertain significance	57
Likely benign	1
Benign	0

Top pathogenic / likely-pathogenic (0)

SpliceAI

2446 predictions. Top by Δscore:

Variant	Effect	Δscore
1:23387267:CCTTA:C	donor_loss	1.0000
1:23387268:CTTA:C	donor_loss	1.0000
1:23387269:TTAC:T	donor_loss	1.0000
1:23387270:TACCT:T	donor_loss	1.0000
1:23387271:A:AC	donor_gain	1.0000
1:23387271:AC:A	donor_gain	1.0000
1:23387271:ACCTG:A	donor_loss	1.0000
1:23387272:C:CC	donor_gain	1.0000
1:23387272:CC:C	donor_gain	1.0000
1:23387272:CCT:C	donor_gain	1.0000
1:23387272:CCTG:C	donor_gain	1.0000
1:23387272:CCTGG:C	donor_gain	1.0000
1:23387416:TTTC:T	acceptor_gain	1.0000
1:23397450:T:TA	donor_gain	1.0000
1:23397459:T:TA	donor_gain	1.0000
1:23417387:GAGT:G	acceptor_gain	1.0000
1:23417391:C:CC	acceptor_gain	1.0000
1:23417391:C:CG	acceptor_loss	1.0000
1:23417392:T:G	acceptor_loss	1.0000
1:23418010:C:CC	acceptor_gain	1.0000
1:23424559:CCTCA:C	donor_loss	1.0000
1:23424560:CTCA:C	donor_loss	1.0000
1:23424561:TCAC:T	donor_loss	1.0000
1:23424562:CACCG:C	donor_loss	1.0000
1:23424563:A:AC	donor_gain	1.0000
1:23424563:ACCGT:A	donor_loss	1.0000
1:23424564:C:CC	donor_gain	1.0000
1:23424573:T:TA	donor_gain	1.0000
1:23381475:C:CC	acceptor_gain	0.9900
1:23387415:ATTTC:A	acceptor_gain	0.9900

AlphaMissense

2297 scored. Top likely-pathogenic:

Variant	Protein change	am_pathogenicity
1:23384349:C:A	W345C	1.000
1:23384349:C:G	W345C	1.000
1:23384351:A:G	W345R	1.000
1:23384351:A:T	W345R	1.000
1:23384362:C:G	C341S	1.000
1:23384363:A:G	C341R	1.000
1:23384363:A:T	C341S	1.000
1:23384370:G:C	C338W	1.000
1:23384371:C:A	C338F	1.000
1:23384371:C:G	C338S	1.000
1:23384371:C:T	C338Y	1.000
1:23384372:A:G	C338R	1.000
1:23384372:A:T	C338S	1.000
1:23384377:A:T	V336D	1.000
1:23384379:A:C	F335L	1.000
1:23384379:A:T	F335L	1.000
1:23384381:A:G	F335L	1.000
1:23384392:G:T	P331H	1.000
1:23384398:T:A	D329V	1.000
1:23384399:C:G	D329H	1.000
1:23384412:C:A	Q324H	1.000
1:23384412:C:G	Q324H	1.000
1:23387273:C:A	Q322H	1.000
1:23387273:C:G	Q322H	1.000
1:23387281:A:C	Y320D	1.000
1:23387285:G:C	C318W	1.000
1:23387301:C:G	C313S	1.000
1:23387302:A:T	C313S	1.000
1:23387310:C:G	C310S	1.000
1:23387311:A:G	C310R	1.000

dbSNP variants (sampled 300 via entrez): RS1000375672 (1:23403715 G>A), RS1000421758 (1:23391935 A>C), RS1000426431 (1:23407950 T>G), RS1000579563 (1:23403062 C>A), RS1000645599 (1:23422389 G>A), RS1001088626 (1:23389845 G>A), RS1001110197 (1:23397253 A>C), RS1001161798 (1:23415858 A>G), RS1001163610 (1:23413377 C>T), RS1001207 (1:23422655 G>A), RS1001223029 (1:23407002 C>T), RS1001257711 (1:23400470 A>G), RS1001323910 (1:23412956 G>A,T), RS1001375235 (1:23419434 A>T), RS1001479559 (1:23396981 G>A)

Disease associations

OMIM: gene MIM:604128 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

60 associations (top):

Study	Trait	p-value
GCST002500_48	QT interval	1.000000e-14
GCST005171_56	QT interval	2.000000e-07
GCST005985_1	Creatinine levels	3.000000e-11
GCST006613_151	Triglycerides	2.000000e-11
GCST006614_90	Total cholesterol levels	4.000000e-08
GCST007324_80	Adventurousness	4.000000e-09
GCST007876_64	Estimated glomerular filtration rate	8.000000e-15
GCST010204_159	Low density lipoprotein cholesterol levels	4.000000e-09
GCST010241_81	Apolipoprotein A1 levels	2.000000e-13
GCST010242_325	HDL cholesterol levels	2.000000e-13
GCST010796_2023	Electrocardiogram morphology (amplitude at temporal datapoints)	3.000000e-08
GCST010796_2024	Electrocardiogram morphology (amplitude at temporal datapoints)	8.000000e-11
GCST010796_2025	Electrocardiogram morphology (amplitude at temporal datapoints)	4.000000e-10
GCST010796_2076	Electrocardiogram morphology (amplitude at temporal datapoints)	4.000000e-16
GCST010796_2077	Electrocardiogram morphology (amplitude at temporal datapoints)	8.000000e-16
GCST010796_2078	Electrocardiogram morphology (amplitude at temporal datapoints)	1.000000e-15
GCST010796_2079	Electrocardiogram morphology (amplitude at temporal datapoints)	2.000000e-15
GCST010796_2080	Electrocardiogram morphology (amplitude at temporal datapoints)	6.000000e-15
GCST010796_2081	Electrocardiogram morphology (amplitude at temporal datapoints)	5.000000e-14
GCST010796_2082	Electrocardiogram morphology (amplitude at temporal datapoints)	8.000000e-13
GCST010796_2083	Electrocardiogram morphology (amplitude at temporal datapoints)	6.000000e-13
GCST010796_2084	Electrocardiogram morphology (amplitude at temporal datapoints)	7.000000e-13
GCST010796_2085	Electrocardiogram morphology (amplitude at temporal datapoints)	3.000000e-12
GCST010796_2086	Electrocardiogram morphology (amplitude at temporal datapoints)	8.000000e-12
GCST010796_2087	Electrocardiogram morphology (amplitude at temporal datapoints)	2.000000e-11
GCST010796_2088	Electrocardiogram morphology (amplitude at temporal datapoints)	3.000000e-10
GCST010796_2089	Electrocardiogram morphology (amplitude at temporal datapoints)	2.000000e-09
GCST010796_2090	Electrocardiogram morphology (amplitude at temporal datapoints)	2.000000e-09
GCST010796_2091	Electrocardiogram morphology (amplitude at temporal datapoints)	4.000000e-09
GCST010796_2092	Electrocardiogram morphology (amplitude at temporal datapoints)	3.000000e-18

EFO canonical traits (10, from GWAS)

EFO ID	Trait name
EFO:0004682	QT interval
EFO:0004530	triglyceride measurement
EFO:0004574	total cholesterol measurement
EFO:0008579	risk-taking behaviour
EFO:0004611	low density lipoprotein cholesterol measurement
EFO:0004614	apolipoprotein A 1 measurement
EFO:0004612	high density lipoprotein cholesterol measurement
EFO:0004327	electrocardiography
EFO:0007991	eosinophil percentage of leukocytes
EFO:0007788	BMI-adjusted waist-hip ratio

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

55 total (human), top 30 by PubMed support.

Chemical	Actions (top 5)	PubMed papers
Estradiol	affects cotreatment, increases expression, decreases expression, affects expression	4
bisphenol A	affects expression, increases expression	2
(+)-JQ1 compound	decreases expression	2
Acetaminophen	decreases expression, increases expression	2
Arsenic	affects methylation, decreases expression, increases abundance	2
Benzo(a)pyrene	affects methylation, decreases expression, decreases methylation	2
Tetrachlorodibenzodioxin	decreases expression	2
Valproic Acid	increases expression, decreases expression	2
Cyclosporine	decreases expression	2
FR900359	affects phosphorylation	1
propionaldehyde	increases expression	1
pirinixic acid	affects binding, decreases expression, increases activity	1
deoxynivalenol	decreases expression	1
sodium arsenate	decreases expression, increases abundance	1
tris(1,3-dichloro-2-propyl)phosphate	decreases expression	1
perfluorooctanoic acid	decreases expression	1
nickel sulfate	decreases expression	1
butylparaben	increases expression	1
S-(1,2-dichlorovinyl)cysteine	affects cotreatment, decreases expression	1
perfluorooctane sulfonic acid	decreases expression	1
perfluoro-n-nonanoic acid	decreases expression	1
entinostat	increases expression	1
K 7174	decreases expression	1
perfluorohexanesulfonic acid	decreases expression	1
nutlin 3	affects cotreatment, increases expression	1
ICG 001	increases expression	1
abrine	increases expression	1
jinfukang	affects cotreatment, increases expression	1
NSC 689534	affects binding, decreases expression	1
4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid	increases expression	1

Cellosaurus cell lines

3 cell lines: 3 embryonic stem cell

First 10 cell lines (id-ordered, not curated):

Cellosaurus	Name	Category	Sex
CVCL_A7B0	SEES3-1V human TCEA3, clone1	Embryonic stem cell	Male
CVCL_A7B1	SEES3-1V human TCEA3, clone2	Embryonic stem cell	Male
CVCL_A7B2	SEES3-1V human TCEA3, clone3	Embryonic stem cell	Male

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.